Showing results (541-550 of 988) with videos related to
Sort By:
Pageof 99
Cancer|July 14, 2011
Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomasMargaret von Mehren, Cathryn Rankin, John R Goldblum, et al.Toxicology and Applied Pharmacology|January 1, 1994
Assay of pulmonary microvascular endothelial angiotensin-converting enzyme in vivo: comparison of three probesS E Orfanos, X L Chen, J W Ryan, et al.Biochemical and Biophysical Research Communications|October 29, 1993
A comparison of guinea pig serum angiotensin converting enzyme with forms of angiotensin converting enzyme from human, rat and rabbit tissuesJ W Ryan, F A Valido, A Y Chung, et al.American Journal of Epidemiology|August 27, 2005
Risk factors for fatal breast cancer in African-American women and White women in a large US prospective cohortMarjorie L McCullough, Heather Spencer Feigelson, W Ryan Diver, et al.Biotechnology and Bioengineering|May 28, 2010
Rapid characterization and quality control of complex cell culture media solutions using raman spectroscopy and chemometricsBoyan Li, Paul W Ryan, Bryan H Ray, et al.Research in Nursing & Health|June 1, 1991
The Patient Intensity for Nursing Index: a validity assessmentP A Prescott, J W Ryan, K L Soeken, et al.Vaccine: X|July 22, 2022
Factors contributing to missed opportunities for human papillomavirus vaccination among adolescents, ages 11 to 13, in IowaGrace W Ryan, Sarah S Perry, Aaron Scherer, et al.BMC Medicine|June 24, 2024
Lung cancer metabolomics: a pooled analysis in the Cancer Prevention StudiesZiyin Tang, Donghai Liang, Emily L Deubler, et al.Toxicology and Applied Pharmacology|January 1, 1994
Radiation-induced early pulmonary endothelial ectoenzyme dysfunction in vivo: effect of indomethacinS E Orfanos, X L Chen, S E Burch, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2009
No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer riskLauren R Teras, Michael Goodman, Alpa V Patel, et al.Pageof 99